Sahin Eroglu, D. et al. 2022. Rituximab experience from a single centre for patients with rheumatoid arthritis-related interstitial lung disease: Rituximab in RA-ILD. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 39, 3 (Sep. 2022), e2022029. DOI:https://doi.org/10.36141/svdld.v39i3.12337.